Results 1 to 10 of about 1,666,541 (346)

Viral Suppression

open access: yesIssues in Science and Technology, 2023
When Facebook’s fact-checkers slapped a “missing context” label on a venerable medical journal’s article about breached vaccine trial protocols, they set off a very twenty-first-century fight about who should play what role in scientific communication.
J. Stilgoe
semanticscholar   +3 more sources

Determinants of viral suppression among adolescents on antiretroviral treatment in Ehlanzeni district, South Africa: a cross-sectional analysis

open access: yesAIDS Research and Therapy, 2021
Background Achieving undetectable viral load is crucial for the reduction of HIV transmissions, AIDS-related illnesses and death. Adolescents (10 to19 years) living with HIV (ALHIV) on antiretroviral treatment (ART) have worse treatment adherence and ...
Emeka F. Okonji   +3 more
doaj   +2 more sources

Viral suppression and associated factors among children tested for HIV viral load at Amhara Public Health Institute, Dessie Branch, Ethiopia: a cross-sectional study

open access: yesBMJ Open, 2023
Objective This study aims to assess viral suppression and associated factors among children tested for HIV viral load at the Amhara Public Health Institute, Dessie Branch, Ethiopia.Design An institutional cross-sectional study was conducted.
Hailu Berihun   +4 more
doaj   +2 more sources

Viral Suppression of RIPK1-Mediated Signaling

open access: yesmBio, 2021
Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) has emerged as a key upstream regulator of cell death and inflammation. RIPK1-mediated signaling governs the outcome of signaling pathways initiated by tumor necrosis factor receptor 1 (TNFR1)
Darshika J. Udawatte, A. Rothman
semanticscholar   +5 more sources

Viral suppression of the interferon system

open access: greenBiochimie, 2007
Type I interferons (IFN-alpha/beta) were originally discovered by their strong and direct antiviral activity [A. Isaacs, J. Lindenmann, Virus interference. I. The interferon, Proc. R. Soc. Lond. B Biol. Sci. 147 (1957) 258-267]. (see review by J. Lindenmann on p. 719, in this issue).
Friedemann Weber, Otto Haller
openalex   +5 more sources

Defining the optimal cut-point of self-reported ART adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study

open access: yesAIDS Research and Therapy, 2021
Background When considering adherence to antiretroviral therapy (ART) for HIV, many different cut-points are used. The primary goals of this study were to identify a level of self-reported medication adherence that best distinguished HIV viral ...
Emma O’Halloran Leach   +5 more
doaj   +2 more sources

Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana

open access: yesAIDS Research and Therapy, 2022
Background Viral suppression remains the most desired outcome in the management of patients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) and this can be achieved by an effective Antiretroviral Therapy (ART).
Stephen Opoku   +11 more
doaj   +2 more sources

Sustained HIV viral suppression among men who have sex with men in the Miami-Dade County Ryan White Program: the effect of demographic, psychosocial, provider and neighborhood factors

open access: yesBMC Public Health, 2020
Background HIV viral suppression is associated with health benefits for people living with HIV and a decreased risk of HIV transmission to others. The objective was to identify demographic, psychosocial, provider and neighborhood factors associated with ...
Diana M. Sheehan   +8 more
doaj   +2 more sources

Viral suppression among HIV-positive patients on antiretroviral therapy in northwestern Nigeria: an eleven-year review of tertiary care centre records, January 2009–December 2019

open access: yesBMC Infectious Diseases, 2021
Background Human Immuno-Deficiency Virus (HIV) remains one of the world’s significant public health challenges. Viral suppression is the key indicator for treatment success in People living with HIV (PLHIV).
Suleiman Bello Abdullahi   +11 more
doaj   +2 more sources

Time required to achieve optimum viral load suppression with Ravidasvir/sofosbuvir in chronic hepatitis C patients with or without compensated cirrhosis [PDF]

open access: goldScientific Reports
A study indicated that ravidasvir (RDV) has excellent safety and tolerability when used with sofosbuvir (SOF) to treat chronic HCV infection. The aim of this study was to determine the time taken by RDV/SOF to achieve optimum viral load suppression in ...
Nor Asiah Muhamad   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy